25 June 2019
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference
19 June 2019
Wellness is currently a buzzword in the world of health. But what does it actually mean?
18 June 2019
Our Policy & Public Affairs Officer, Helena Brown, reports from Scotland
17 June 2019
Our funded research has created a tool to help clinicians predict meningioma recurrence
17 June 2019
Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of ...
14 June 2019
In February, we co-signed a joint letter with other cancer charities to the Secretary of State for Health and Social Care which outlined concerns regarding cancer research in the UK ...
13 June 2019
Earlier this month, NHS England released their ‘Interim NHS People’s Plan’ detailing what measures will be implemented in and ahead of their full workforce proposal
13 June 2019
Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm ...
10 June 2019
Most people find exams stressful and it's safe to say that living with a brain tumour doesn't make them any easier! Kaleb Ells, a member of our young adults community, ...
28 May 2019
After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue
24 May 2019
The Health Secretary, Matt Hancock, has spoken today of his frustration at slow progress towards embracing digital technology in the NHS.
22 May 2019
Side by side, stride by stride, let’s pick up the pace of progress
21 May 2019
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
16 May 2019
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
15 May 2019
Chartered Clinical Psychologist, Dr Nick Mooney, offers advice on how best to start talking with your family and friends about brain tumours.
15 May 2019
New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma
14 May 2019
There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients
09 May 2019
A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)